Average Co-Inventor Count = 2.76
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Iovance Biotherapeutics, Inc. (47 from 92 patents)
2. Lovance Biotherapeutics, Inc. (4 from 4 patents)
51 patents:
1. 12453697 - Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
2. 12280140 - Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
3. 12226434 - Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
4. 12226522 - Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
5. 12194061 - Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
6. 12121541 - Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
7. 11998568 - Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
8. 11939596 - Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
9. 11541077 - Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
10. 11529372 - Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
11. 11517592 - Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
12. 11344579 - Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
13. 11337998 - Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
14. 11304979 - Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
15. 11291687 - Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy